Literature DB >> 19221018

Activation of guanylate cyclase C signaling pathway protects intestinal epithelial cells from acute radiation-induced apoptosis.

M P Garin-Laflam1, K A Steinbrecher, J A Rudolph, J Mao, M B Cohen.   

Abstract

Uroguanylin (UGN) is a peptide hormone that binds to and activates the intestinal epithelial cell (IEC) transmembrane receptor guanylate cyclase C (GC-C), which in turn increases intracellular cGMP. Gene targeting of murine UGN or GC-C results in significantly lower levels of cGMP in IECs. On the basis of effects of cGMP in nonintestinal systems, we hypothesized that loss of GC-C activation would increase intestinal epithelial apoptosis following radiation-induced injury. We first compared apoptosis from the proximal jejunum of C57BL/6 wild-type (WT) and GC-C knockout (KO) mice 3 h after they received 5 Gy of gamma-irradiation. We then investigated whether supplementation via intraperitoneal injection of 1 mM 8BrcGMP would mitigate radiation-induced apoptosis in these experimental animals. Identical experiments were performed in BALB/c UGN WT and KO mice. Apoptosis was assessed by quantitating morphological indications of cell death, terminal dUTP nick-end labeling, and cleaved caspase 3 immunohistochemistry. Both UGN KO and GC-C KO mice were more susceptible than their WT littermates in this in vivo model of apoptotic injury. Furthermore, cGMP supplementation in both GC-C and UGN KO animals ameliorated radiation-induced apoptosis. Neither WT strain demonstrated significant alteration in apoptotic susceptibility as a result of cGMP supplementation before radiation injury. These in vivo findings demonstrate increased radiosensitivity of IECs in UGN and GC-C KO mice and a role for cGMP as a primary downstream mediator of GC-C activation in the protection of these IECs from radiation-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19221018      PMCID: PMC2670662          DOI: 10.1152/ajpgi.90268.2008

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  31 in total

1.  Radiation, the ideal cytotoxic agent for studying the cell biology of tissues such as the small intestine.

Authors:  Christopher S Potten
Journal:  Radiat Res       Date:  2004-02       Impact factor: 2.841

2.  Guanylyl cyclase inhibitors NS2028 and ODQ and protein kinase G (PKG) inhibitor KT5823 trigger apoptotic DNA fragmentation in immortalized uterine epithelial cells: anti-apoptotic effects of basal cGMP/PKG.

Authors:  Siu Lan Chan; Ronald R Fiscus
Journal:  Mol Hum Reprod       Date:  2003-12       Impact factor: 4.025

3.  Control of survival of proliferating L1210 cells by soluble guanylate cyclase and p44/42 mitogen-activated protein kinase modulators.

Authors:  F Flamigni; A Facchini; I Stanic; B Tantini; F Bonavita; C Stefanelli
Journal:  Biochem Pharmacol       Date:  2001-08-01       Impact factor: 5.858

4.  Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells.

Authors:  G M Pitari; M D Di Guglielmo; J Park; S Schulz; S A Waldman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

5.  Identification of an apical Cl(-)/HCO3(-) exchanger in the small intestine.

Authors:  Zhaohui Wang; Snezana Petrovic; Elizabeth Mann; Manoocher Soleimani
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-03       Impact factor: 4.052

6.  Bax is required for increased enterocyte apoptosis after massive small bowel resection.

Authors:  L E Stern; F Huang; C J Kemp; R A Falcone; C R Erwin; B W Warner
Journal:  Surgery       Date:  2000-08       Impact factor: 3.982

7.  Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis.

Authors:  Craig M Coopersmith; Paul E Stromberg; W Michael Dunne; Christopher G Davis; Daniel M Amiot; Timothy G Buchman; Irene E Karl; Richard S Hotchkiss
Journal:  JAMA       Date:  2002-04-03       Impact factor: 56.272

8.  Nitric oxide prevents oxidised LDL-induced p53 accumulation, cytochrome c translocation, and apoptosis in macrophages via guanylate cyclase stimulation.

Authors:  Alexandra Heinloth; Bernhard Brüne; Barbara Fischer; Jan Galle
Journal:  Atherosclerosis       Date:  2002-05       Impact factor: 5.162

9.  Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP.

Authors:  K Shailubhai; H H Yu; K Karunanandaa; J Y Wang; S L Eber; Y Wang; N S Joo; H D Kim; B W Miedema; S Z Abbas; S S Boddupalli; M G Currie; L R Forte
Journal:  Cancer Res       Date:  2000-09-15       Impact factor: 12.701

10.  Uroguanylin knockout mice have increased blood pressure and impaired natriuretic response to enteral NaCl load.

Authors:  John N Lorenz; Michelle Nieman; Jenine Sabo; L Philip Sanford; Jennifer A Hawkins; Noeet Elitsur; Lara R Gawenis; Lane L Clarke; Mitchell B Cohen
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

View more
  19 in total

1.  GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome.

Authors:  Peng Li; Evan Wuthrick; Jeff A Rappaport; Crystal Kraft; Jieru E Lin; Glen Marszalowicz; Adam E Snook; Tingting Zhan; Terry M Hyslop; Scott A Waldman
Journal:  Cancer Res       Date:  2017-09-15       Impact factor: 12.701

Review 2.  Can colorectal cancer be prevented or treated by oral hormone replacement therapy?

Authors:  P Li; J E Lin; S Schulz; G M Pitari; S A Waldman
Journal:  Curr Mol Pharmacol       Date:  2009-11       Impact factor: 3.339

3.  Murine guanylate cyclase C regulates colonic injury and inflammation.

Authors:  Kris A Steinbrecher; Eleana Harmel-Laws; Monica P Garin-Laflam; Elizabeth A Mann; Lucas D Bezerra; Simon P Hogan; Mitchell B Cohen
Journal:  J Immunol       Date:  2011-05-09       Impact factor: 5.422

Review 4.  Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer.

Authors:  Allison A Aka; Jeff A Rappaport; Amanda M Pattison; Takami Sato; Adam E Snook; Scott A Waldman
Journal:  Expert Rev Clin Pharmacol       Date:  2017-04-10       Impact factor: 5.045

5.  cGMP Signaling Increases Antioxidant Gene Expression by Activating Forkhead Box O3A in the Colon Epithelium.

Authors:  Rui Wang; Bianca N Islam; Allison Bridges; Sarah K Sharman; Muhan Hu; Yali Hou; Payaningal R Somanath; Laine Venable; Nagendra Singh; Sangmi Kim; Subbaramiah Sridhar; Franz Hofmann; Darren D Browning
Journal:  Am J Pathol       Date:  2016-12-18       Impact factor: 4.307

6.  Lack of guanylate cyclase C results in increased mortality in mice following liver injury.

Authors:  Elizabeth A Mann; Kumar Shanmukhappa; Mitchell B Cohen
Journal:  BMC Gastroenterol       Date:  2010-08-02       Impact factor: 3.067

Review 7.  Microbial influences on the small intestinal response to radiation injury.

Authors:  Christopher D Packey; Matthew A Ciorba
Journal:  Curr Opin Gastroenterol       Date:  2010-03       Impact factor: 3.287

Review 8.  Gut microbiome influences on anastomotic leak and recurrence rates following colorectal cancer surgery.

Authors:  S Gaines; C Shao; N Hyman; J C Alverdy
Journal:  Br J Surg       Date:  2018-01       Impact factor: 6.939

9.  Type 2 cGMP-dependent protein kinase regulates homeostasis by blocking c-Jun N-terminal kinase in the colon epithelium.

Authors:  R Wang; I-K Kwon; N Singh; B Islam; K Liu; S Sridhar; F Hofmann; D D Browning
Journal:  Cell Death Differ       Date:  2013-11-22       Impact factor: 15.828

10.  Guanylate cyclase C limits systemic dissemination of a murine enteric pathogen.

Authors:  Elizabeth A Mann; Eleana Harmel-Laws; Mitchell B Cohen; Kris A Steinbrecher
Journal:  BMC Gastroenterol       Date:  2013-09-02       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.